PubRank

Fergus Shanahan

Author PubWeight™ 187.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The gut flora as a forgotten organ. EMBO Rep 2006 7.42
2 Gut microbiota composition correlates with diet and health in the elderly. Nature 2012 6.94
3 Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005 5.75
4 Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2010 5.02
5 Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 2010 4.45
6 Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006 3.24
7 Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006 2.93
8 Multireplicon genome architecture of Lactobacillus salivarius. Proc Natl Acad Sci U S A 2006 2.43
9 Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol 2009 2.34
10 Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006 2.28
11 Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 2012 2.24
12 Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A 2011 2.22
13 Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 2008 2.21
14 The role of substance P in inflammatory disease. J Cell Physiol 2004 2.19
15 Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A 2010 2.11
16 Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 2012 2.09
17 Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002 2.07
18 Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2010 2.02
19 Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007 1.99
20 Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 2011 1.96
21 Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2011 1.78
22 Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006 1.73
23 The mycobacteria story in Crohn's disease. Am J Gastroenterol 2005 1.71
24 Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 2013 1.63
25 Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 2012 1.59
26 Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol 2008 1.56
27 Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008 1.54
28 Celiac disease and the transition from childhood to adulthood: a 28-year follow-up. Am J Gastroenterol 2004 1.53
29 The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012 1.52
30 Radiologic imaging in cystic fibrosis: cumulative effective dose and changing trends over 2 decades. Chest 2011 1.49
31 Radiation exposure from diagnostic imaging among patients with gastrointestinal disorders. Clin Gastroenterol Hepatol 2011 1.48
32 Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J 2009 1.43
33 Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 2008 1.42
34 World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012 1.39
35 A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2009 1.39
36 Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol 2011 1.34
37 Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J Med Microbiol 2007 1.33
38 A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol 2013 1.32
39 Categorization of the gut microbiota: enterotypes or gradients? Nat Rev Microbiol 2012 1.31
40 Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals. FEMS Microbiol Ecol 2009 1.31
41 Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003 1.30
42 Probiotic effects on inflammatory bowel disease. J Nutr 2007 1.29
43 Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's disease. Inflamm Bowel Dis 2010 1.27
44 Bacterial DNA within granulomas of patients with Crohn's disease--detection by laser capture microdissection and PCR. Am J Gastroenterol 2004 1.21
45 The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009 1.16
46 Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009 1.15
47 Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Infect Immun 2010 1.12
48 Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 2005 1.12
49 Intestinal tuberculosis mimicking Crohn's disease: lessons relearned in a new era. Eur J Gastroenterol Hepatol 2007 1.12
50 Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 2008 1.11
51 The normal intestinal microbiota. Curr Opin Infect Dis 2007 1.11
52 Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 2010 1.11
53 Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis. Dig Dis Sci 2010 1.10
54 Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008 1.10
55 Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010 1.10
56 Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 2009 1.07
57 Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo. Cancer Res 2005 1.06
58 Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 2012 1.06
59 Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol 2013 1.03
60 Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One 2013 1.01
61 Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 2013 1.01
62 Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol 2008 1.00
63 Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. Hum Immunol 2004 0.99
64 Probiotics in perspective. Gastroenterology 2010 0.96
65 Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 2003 0.96
66 The microbiota in inflammatory bowel disease. J Gastroenterol 2015 0.95
67 Mechanisms of action of probiotics in intestinal diseases. ScientificWorldJournal 2007 0.95
68 Fas ligand promotes tumor immune evasion of colon cancer in vivo. Cell Cycle 2006 0.95
69 Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 2012 0.93
70 Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol 2007 0.93
71 Role of radiologic imaging in irritable bowel syndrome: evidence-based review. Radiology 2011 0.93
72 Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis. Nat Immunol 2013 0.92
73 CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J Bone Miner Metab 2006 0.92
74 Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells. Immunology 2010 0.92
75 Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. Am J Physiol Gastrointest Liver Physiol 2012 0.91
76 Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo. Int J Cancer 2003 0.91
77 Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 2012 0.91
78 Cogan's syndrome: present and future directions. Rheumatol Int 2009 0.90
79 Diagnostic accuracy of computed tomography using lower doses of radiation for patients with Crohn's disease. Clin Gastroenterol Hepatol 2012 0.90
80 Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo. BMC Immunol 2010 0.90
81 Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol 2009 0.90
82 Manipulation of the bacterial flora in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2003 0.89
83 Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect Immun 2012 0.88
84 Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2010 0.88
85 Thromboembolism--an important manifestation of inflammatory bowel disease. Am J Gastroenterol 2004 0.88
86 A prospective feasibility study of sub-millisievert abdominopelvic CT using iterative reconstruction in Crohn's disease. Eur Radiol 2013 0.88
87 Targeting the Fas/Fas ligand pathway in cancer. Expert Opin Ther Targets 2005 0.87
88 Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P. J Cell Physiol 2003 0.87
89 IgG-mediated food intolerance in irritable bowel syndrome: a real phenomenon or an epiphenomenom? Am J Gastroenterol 2005 0.86
90 Drug interactions in inflammatory bowel disease. Am J Gastroenterol 2007 0.86
91 Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation. Immunology 2009 0.86
92 An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K. Rheumatology (Oxford) 2010 0.86
93 Correlation of probiotic Lactobacillus salivarius growth phase with its cell wall-associated proteome. FEMS Microbiol Lett 2005 0.86
94 Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy. J Surg Res 2004 0.85
95 Technical Advance: Function and efficacy of an {alpha}4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis. J Leukoc Biol 2010 0.84
96 Impact of administered bifidobacterium on murine host fatty acid composition. Lipids 2010 0.84
97 Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. Microbiology 2010 0.84
98 Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 2011 0.84
99 Differential intestinal M-cell gene expression response to gut commensals. Immunology 2012 0.83
100 Exercise and the microbiota. Gut Microbes 2015 0.83
101 The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium. Infect Immun 2012 0.83
102 IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol 2010 0.83
103 Esophageal intramural pseudodiverticulosis characterized by barium esophagography: a case report. J Med Case Rep 2010 0.83
104 Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. Microbiology 2013 0.82
105 The hybrid science of diet, microbes, and metabolic health. Am J Clin Nutr 2011 0.82
106 Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer. Int J Cancer 2013 0.82
107 Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome. PLoS One 2012 0.82
108 Nested RT-PCR. Sensitivity controls are essential to determine the biological significance of detected mRNA. Methods Mol Biol 2002 0.82
109 CT-based estimation of intracavitary gas volumes using threshold-based segmentation: in vitro study to determine the optimal threshold range. J Med Imaging Radiat Oncol 2012 0.82
110 Shining a light on intestinal traffic. Clin Dev Immunol 2011 0.82
111 Bifidobacterium infantis 35624 protects against salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response. Clin Transl Gastroenterol 2012 0.81
112 Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease. FEMS Immunol Med Microbiol 2009 0.81
113 Activation of the p38 MAPK and ERK1/2 pathways is required for Fas-induced IL-8 production in colonic epithelial cells. Ann N Y Acad Sci 2002 0.81
114 Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol 2004 0.81
115 Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk. Gut Microbes 2014 0.80
116 Identification of a unique hybrid macrophage-polarization state following recovery from lipopolysaccharide tolerance. J Immunol 2013 0.80
117 Irritable bowel syndrome: shifting the focus toward the gut microbiota. Gastroenterology 2007 0.80
118 Prevalence and characterization of Clostridium perfringens from the faecal microbiota of elderly Irish subjects. J Med Microbiol 2012 0.80
119 Depth-dependent differences in community structure of the human colonic microbiota in health. PLoS One 2013 0.80
120 Are patients with IBD knowledgeable about the risks of their medications? Inflamm Bowel Dis 2008 0.80
121 Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse. Pulm Pharmacol Ther 2012 0.79
122 Digestion of epithelial tight junction proteins by the commensal Clostridium perfringens. Am J Physiol Gastrointest Liver Physiol 2013 0.79
123 Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data. J Carcinog 2006 0.79
124 Role of probiotics in the treatment of intestinal infections and inflammation. Curr Opin Gastroenterol 2002 0.79
125 Exercise, fitness, and the gut. Curr Opin Gastroenterol 2016 0.79
126 Food allergies. Curr Gastroenterol Rep 2002 0.79
127 Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B). Med Microbiol Immunol 2014 0.78
128 Mycobacterium paratuberculosis detected by nested PCR in intestinal granulomas isolated by LCM in cases of Crohn's disease. Methods Mol Biol 2002 0.78
129 Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis. J Clin Immunol 2003 0.78
130 Undiagnosed maternal celiac disease in pregnancy and an increased risk of fetal growth restriction. J Clin Gastroenterol 2009 0.78
131 Carriage of Clostridium difficile in outpatients with irritable bowel syndrome. J Med Microbiol 2012 0.78
132 Host-microbe interactions and spatial variation of cancer in the gut. Nat Rev Cancer 2014 0.78
133 Soluble interleukin 2 receptor levels in families of people with schizophrenia. Schizophr Res 2002 0.78
134 Risk factors for hand injury in hurling: a cross-sectional study. BMJ Open 2013 0.78
135 The utilisation and diagnostic yield of radiological imaging in a specialist functional GI disorder clinic: an 11-year retrospective study. Eur Radiol 2014 0.77
136 Minimization of Radiation Exposure due to Computed Tomography in Inflammatory Bowel Disease. ISRN Gastroenterol 2012 0.77
137 Computed tomography assessment of intestinal gas volumes in functional gastrointestinal disorders. J Neurogastroenterol Motil 2012 0.77
138 Exploring the iceberg--the spectrum of celiac disease. Am J Gastroenterol 2003 0.77
139 Infliximab therapy for complicated sarcoidosis. Ann Intern Med 2002 0.76
140 Inflammatory bowel disease—from mechanisms to treatment strategies. Autoimmunity 2010 0.76
141 Changing the narrative on antibiotics. Gut 2015 0.76
142 Pure Iterative Reconstruction Improves Image Quality in Computed Tomography of the Abdomen and Pelvis Acquired at Substantially Reduced Radiation Doses in Patients With Active Crohn Disease. J Comput Assist Tomogr 2016 0.76
143 Genotoxicity of fecal water in a free-living Irish population. Nutr Cancer 2002 0.76
144 The small bowel microbiota. Curr Opin Gastroenterol 2015 0.76
145 Antimicrobials: Strategies for targeting obesity and metabolic health? Gut Microbes 2012 0.76
146 The language of medicine: words as servants and scoundrels. Clin Med 2009 0.75
147 Coeliac disease. Don't forget increased risk of fetal growth restriction. BMJ 2009 0.75
148 Making microbes work for mankind--clever trick or a glimpse of the future for IBD treatment? Gastroenterology 2004 0.75
149 The future of probiotics for disorders of the brain-gut axis. Adv Exp Med Biol 2014 0.75
150 Effective therapy for advanced gastrointestinal stromal tumors. Gastroenterology 2003 0.75
151 Clinical examination of the gastrointestinal system in the 21st century--is the emphasis right? Am J Gastroenterol 2004 0.75
152 Ethereal and material gain: unanticipated opportunity with illness or disability. Clin Med 2014 0.75
153 Viral discrimination and subversion of host defense at the epithelial gateway. Gastroenterology 2002 0.75
154 Type I insulin-like growth factor receptor expression on colorectal adenocarcinoma cell lines is decreased in response to the chemopreventive agent N-acetyl-l-cysteine. Ann N Y Acad Sci 2002 0.75
155 Selection of symptomatic patients with Crohn's disease for abdominopelvic computed tomography: role of serum C-reactive protein. Can Assoc Radiol J 2012 0.75
156 Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol 2012 0.75
157 RT-PCR for the assessment of genetically heterogenous populations of the hepatitis C virus. Methods Mol Biol 2002 0.75
158 Chronic gastroenterologic and hepatic disorders. Best Pract Res Clin Gastroenterol 2007 0.75